Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...

Why contrarians should take note of UTX

A contrarian-related boost may be on the cards for manufacturer United Technologies Corp. ( NYSE: UTX , Stock Forum ) which could help the stock surmount a formidable technical wall, allowing it to extend its quest for new stock market highs. United Technologies has bee...

Evotec, Memphasys, MorphoSys - Growth Industry Health

He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are a...

XPhyto to Announce PCR Test Kit Final Validation Results

It could be the Holy Grail of COVID-19 testing. Remarkably, a small Canadian life sciences company, XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) is becoming a front-runner in the race to bring this breakthrough technology to market – starting with Germany. This ref...

AOL, Inc. (AOL): Can it fly in the face of skepticism?

Late last week, analysts at Macquarie launched coverage of AOL, Inc. ( NYSE: AOL , Stock Forum ) with a "neutral" rating and a $27 price target, essentially implying that they don't expect the stock to move much higher in the near future. Nevertheless, unenthusiastic ra...

Will Fed and Trump Save the US Economy And Sink Gold?

The Trump administration will seek an additional $250 billion to support small businesses hurt by the widespread economic shutdown and slowdown. Will the government and the Fed save the US economy? What would be the consequences for the gold market? US Epidemiological Upda...

The Message From The Stock/Bond Ratio

BONDS WERE EXTENDED AT THE END OF MAY Rare extended look on May 31, 2019. A June 4 post outlined an extremely rare and extended condition in the bond market that had only occurred ten times in the past thirty-three years. The historical cases told us to be open to a pe...

Amazon.com, Enthusiast Gaming, Netflix - perspectives of scalable business models

Modern society is constantly finding new ways to simplify life and increase comfort. For example, there are now successful business models that would have been unimaginable decades ago. The monetization of access to the customer, for example in the areas of entertainment, gami...

Daimler, SAP, Triumph Gold - the changing world offers opportunities

What is the next big trend or with what can you achieve a decent return in the next days, weeks, months or even years? These are the questions that investors are currently asking themselves because the world and the investment environment have changed dramatically since the ou...

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
1 2 3 4 5 6 7 8 9 10 ...